Skip to content
ppharmaranks
Menu

Best treatments for hyperparathyroidism

4 products may treat hyperparathyroidism, spanning FDA drug classes such as vitamin d analog, vitamin d2 analog, vitamin d3 analog. The current highest-rated option is paricalcitol. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 4 drugs we list for hyperparathyroidism, all are available as lower-cost generics, spanning classes such as vitamin d analog, vitamin d2 analog, vitamin d3 analog. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for hyperparathyroidism — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Top-rated picks for hyperparathyroidism: 1. Paricalcitol · 2. Zemplar · 3. Rocaltrol

Top-rated treatments for hyperparathyroidism, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$45View →
270/100$45View →
3Not yet rated$5View →
4Not yet rated$5View →

Full ranking · 4 treatments

Frequently asked

What treats hyperparathyroidism?
Our catalog lists 4 products that may treat hyperparathyroidism, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is paricalcitol.
What is the best-rated treatment for hyperparathyroidism?
By our independent recall-safety rating — not an efficacy measure — paricalcitol ranks highest among the products we list for hyperparathyroidism. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat hyperparathyroidism?
Treatments for hyperparathyroidism span FDA drug classes including vitamin d analog, vitamin d2 analog, vitamin d3 analog. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.